Family Management Corp Iveric Bio, Inc. Transaction History

Family Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.07 - $17.5 $83,461 - $206,587	-11,805 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$5.69 - $7.17 $21,024 - $26,493	-3,695 Reduced 23.84%	11,805 $74,000
Q1 2021 May 14, 2021	SELL	$5.08 - $6.89 $55,880 - $75,790	-11,000 Reduced 41.51%	15,500 $96,000
Q4 2020 Feb 10, 2021	BUY	$5.65 - $7.66 $62,150 - $84,260	11,000 Added 70.97%	26,500 $183,000
Q3 2020 Nov 13, 2020	BUY	$4.01 - $6.29 $62,155 - $97,495	15,500 New	15,500 $87,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

Stay updated on Family Management Corp with notifications on news.